Selecta Biosciences Inc
Price
$4.56
Today
+3.4%
YTD
+0.0%
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel RNA-engineered cell therapies designed to treat autoimmune diseases. The company is steadfast in its development efforts to address significant unmet patient needs through innovative therapeutic approaches. Operating within the biotechnology sector, Cartesian Therapeutics Inc focuses on advancing its pipeline of RNA cell therapies. These therapies are designed to potentially offer improved safety profiles and outpatient administration for treating severe autoimmune conditions. Monitor the RNAC share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
No daily candle data is currently available for this instrument.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Valuation
Profitability
Earnings & Revenue
Dividends & Risk
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.